Tom brings proven, hands-on experience as a senior executive who has transformed businesses, established new market opportunities, and driven growth in the face of strong competition. His extensive leadership experience across start-ups to larger corporate organizations helps him recognize and optimize business value. Tom understands how to promote growth by building organizational capabilities, optimizing product portfolios, developing innovative go-to-market models, and establishing processes for effective management.

Throughout his career, Tom has led successful businesses in virtually every clinical segment of the medical device and regenerative medicine markets. More importantly, he drove disruption in multi-billion-dollar markets creating unique new market segments such as point-of-care ultrasound, disposable negative pressure wound therapy, intelligent access systems for robotic and laparoscopic surgery, orthopedic osseointegration, and the clinical application of human placental tissues.

As a co-founder of 360 Life Sciences Advisors, Tom works with private equity and venture capital firms to assess new investment opportunities and improve performance at portfolio companies. His role as a counselor to both start-ups and established companies involves providing strategic, commercial, and operational guidance to address various challenges. Tom serves as Chairman of the Board of Directors of BioStem Technologies, Inc., a leader in amniotic tissue-based regenerative medicine therapies. He is also Chairman of the Board for TYBR Health, a start-up focused on prevention of surgical adhesions.

He was President of Integrum, Inc., the pioneer in osseointegrated orthopedic implants that improve the lives of those with limb loss. Serving as the CEO and board member of Amniox Medical (BioTissue, Inc.), the pioneer and leader in the clinical application of human placental tissues in wound care and orthopedic surgery, he transformed the company implementing processes, systems, and personnel changes leading to significant growth and access to new market segments. Tom was the President and board member of SurgiQuest, a start-up that revolutionized access management in robotic and laparoscopic surgery, which was acquired by ConMed for $265M. At Smith & Nephew Tom was President of Americas and served on the Global Executive Management team of the $1.3 billion wound management business. He led a turnaround, driving growth at over twice the market rate, and established Smith & Nephew as a leading player in the negative pressure wound therapy market against a strong monopoly. Previously Tom served as Senior Vice President at SonoSite, the world leader in point-of-care ultrasound, with responsibility for the U.S. business, worldwide marketing, business development, and investor relations. He drove growth over 20% annually leading to SonoSite’s acquisition by Fujifilm for $995M.

Tom also served as President of InterVascular, Inc. and Corporate Vice President of Business Development of Datascope. He was the Vice President of Marketing at U.S. Surgical/Tyco Healthcare (now Covidien/Medtronic) and ran business development during a period of significant M&A activity with multiple acquisitions and divestitures that transformed the corporation. Earlier in his career, Tom held various sales, marketing, and international positions of increasing responsibility with C.R. Bard, Puritan-Bennett, and Johnson & Johnson.

He also worked with the Life Sciences Incubator at the Mayo Clinic to create and mentor leadership teams of newly formed companies. Tom served on the board of directors of Rita Medical Systems (NASDAQ: RITA), which was acquired by AngioDynamics, and various venture-backed medical device companies. He chaired the Wound Healing and Tissue Regeneration sector of AdvaMed and served on the board of MITA, the industry trade group for medical imaging.